A carregar...
Future of anti-PD-1/PD-L1 applications: Combinations with other therapeutic regimens
Programmed cell death 1 (PD-1)/programmed cell death 1 ligand (PD-L1) blockade has shown promising effects in cancer immunotherapy. Removing the so-called " brakes” on T cell immune responses by blocking the PD-1/PD-L1 check point should boost anti-tumor immunity and provide durable tumor regre...
Na minha lista:
| Publicado no: | Chin J Cancer Res |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AME Publishing Company
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5953954/ https://ncbi.nlm.nih.gov/pubmed/29861603 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21147/j.issn.1000-9604.2018.02.01 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|